Company news
Repligen Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Repligen to Report Second Quarter 2021 Financial Results
July 12, 2021
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
June 21, 2021
Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
May 3, 2021
Repligen to Report First Quarter 2021 Financial Results
April 19, 2021
Repligen Corporation to Present at Barclays Global Healthcare Conference
March 2, 2021
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
February 23, 2021
Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
February 21, 2021
Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
February 10, 2021
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
February 7, 2021
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
January 3, 2021
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters’ Option
December 9, 2020
Repligen Corporation Prices Public Offering of Shares of Common Stock
December 6, 2020
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
December 6, 2020
Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
November 4, 2020
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
October 26, 2020
Repligen to Report Third Quarter 2020 Financial Results
October 21, 2020
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
September 30, 2020
Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
July 29, 2020
Repligen to Report Second Quarter 2020 Financial Results
July 14, 2020
Repligen Announces Agreement to Acquire Engineered Molding Technology
June 28, 2020
Repligen Appoints Carrie Eglinton Manner to Board of Directors
June 14, 2020
Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
May 5, 2020
Repligen to Report First Quarter 2020 Financial Results
April 21, 2020
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
February 26, 2020
Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
February 19, 2020
Repligen to Report Fourth Quarter and Full Year 2019 Financial Results
February 5, 2020
Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020
Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
October 30, 2019
Repligen to Report Third Quarter 2019 Financial Results
October 22, 2019
Investor Network: Repligen Corporation to Host Earnings Call
August 3, 2017
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Repligen (NASDAQ:RGEN) Q3 2026 Earnings Call
Oct 27, 2026
Transcript - Repligen (NASDAQ:RGEN) Q2 2026 Earnings Call
Jul 28, 2026
Transcript - Repligen (NASDAQ:RGEN) Q1 2026 Earnings Call
May 5, 2026
Transcript - Repligen (NASDAQ:RGEN) Q4 2025 Earnings Call
Feb 24, 2026
Transcript - Repligen (NASDAQ:RGEN) Q3 2025 Earnings Call
Oct 28, 2025
Transcript
Decks
The 5 newest of 23 decks. Every deck is listed under its year.
- Wells Fargo 21st Annual Healthcare Conference 2026
Conference · 32 slides · September 2026
- Q2 2026 Earnings Presentation
Earnings · 29 slides · Jul 28, 2026
- Merger or Acquisition (July 2026)
Merger or acquisition · 14 slides · Jul 22, 2026
- J.P. Morgan 2026 Healthcare Conference
Conference · 28 slides · Jan 13, 2026
- Investor Presentation (November 2025)
Investor deck · 33 slides · November 2025